Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Peter MacCallum Cancer Centre
Scientific Title
Phase Ib/II Study of Radionuclide 177Lutetium-PSMA-617 Therapy in Combination With Pembrolizumab for Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC)